Polymorphisms in inflammation pathway genes and endometrial cancer risk.

Delahanty RJ, Xiang YB, Spurdle A, Beeghly-Fadiel A, Long J, Thompson D, Tomlinson I, Yu H, Lambrechts D, Dörk T, Goodman MT, Zheng Y, Salvesen HB, Bao PP, Amant F, Beckmann MW, Coenegrachts L, Coosemans A, Dubrowinskaja N, Dunning A, Runnebaum IB, Easton D, Ekici AB, Fasching PA, Halle MK, Hein A, Howarth K, Gorman M, Kaydarova D, Krakstad C, Lose F, Lu L, Lurie G, O'Mara T, Matsuno RK, Pharoah P, Risch H, Corssen M, Trovik J, Turmanov N, Wen W, Lu W, Cai Q, Zheng W, Shu XO
Cancer Epidemiol Biomarkers Prev. 2013 22 (2): 216-23

PMID: 23221126 · PMCID: PMC3677562 · DOI:10.1158/1055-9965.EPI-12-0903

MeSH Terms (18)

Asians Biomarkers, Tumor Case-Control Studies China Endometrial Neoplasms Female Follow-Up Studies Gene Expression Profiling Genetic Predisposition to Disease Humans Inflammation Linkage Disequilibrium Middle Aged Neoplasm Staging Oligonucleotide Array Sequence Analysis Polymorphism, Single Nucleotide Prognosis Risk Factors

Connections (6)

This publication is referenced by other Labnodes entities: